Download PDF

Other users also viewed these articles

Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Jesús Tornero-Molina; Mercedes Alperi-López; Ivan Castellví; Juan José de Agustín-de Oro; Alejandro Escudero; Rosario García-Vicuña; Miguel Ángel González-Gay; Cristina Hidalgo; Esteban Rubio; Raimon Sanmartí; Núria Casamira; Jaime Calvo-Alén;
Reumatol Clin. 2022;18:33-41
Update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological and synthetic targeted therapies in rheumatoid arthritis José María Álvaro-Gracia Álvaro; Petra Díaz del Campo Fontecha; José Luis Andréu Sánchez; Alejandro Balsa Criado; Rafael Cáliz Cáliz; Isabel Castrejón Fernández; Hèctor Corominas; José A. Gómez Puerta; Sara Manrique Arija; Natalia Mena Vázquez; Ana Ortiz García; Chamaida Plasencia Rodríguez; Lucía Silva Fernández; Jesús Tornero Molina;
Reumatol Clin. 2024;20:423-39
Expert recommendations on the interleukin 6 blockade in patients with rheumatoid arthritis Jesús Tornero Molina; Alejandro Balsa Criado; Francisco Blanco García; Ricardo Blanco Alonso; Sagrario Bustabad; Jaime Calvo Alen; Héctor Corominas; Antonio Fernández Nebro; Jose Andrés Román Ivorra; Raimon Sanmartí;
Reumatol Clin. 2020;16:272-81